| P50 | author | Birgit Weinberger | Q43267559 |
| P2093 | author name string | B Weinberger | |
| P2860 | cites work | Safety and immunogenicity of a tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis vaccine when co-administered with influenza vaccine in adults. | Q51137832 |
| | Immunity to diphtheria and tetanus in England and Wales. | Q52025421 |
| | The sero-epidemiology of diphtheria in Western Europe. ESEN Project. European Sero-Epidemiology Network. | Q53331272 |
| | Susceptibility to diphtheria in adults: prevalence and relationship to gender and social variables. | Q54141138 |
| | A study of the factors influencing tetanus immunity in Israeli male adults. | Q54390621 |
| | A population-based serologic survey of immunity to tetanus in the United States | Q72560077 |
| | Diphtheria immunity in Flanders | Q73834193 |
| | Diphtheria antibody levels in the Italian Population | Q74185846 |
| | Immunogenicity and reactogenicity of the adult tetanus-diphtheria vaccine. How many doses are necessary? | Q77548100 |
| | Booster vaccination in the elderly: their success depends on the vaccine type applied earlier in life as well as on pre-vaccination antibody titers | Q80006417 |
| | Insufficient protection for healthy elderly adults by tetanus and TBE vaccines | Q81661572 |
| | Combined reduced-antigen-content diphtheria-tetanus-acellular pertussis and polio vaccine (dTpa-IPV) for booster vaccination of adults | Q81729221 |
| | Coalition of advocates to vaccinate of Western European citizens aged 60 years and older | Q84156012 |
| | Immunogenicity of the reduced-antigen-content dTpa vaccine (Boostrix(®)) in adults 55 years of age and over: a sub-analysis of four trials | Q84478946 |
| | Diphtheria in the former Soviet Union: reemergence of a pandemic disease | Q30432323 |
| | Analysis of vaccination data of patients aged 60 years and older from Bavaria and Thuringia | Q30976776 |
| | CD4 T cell memory derived from young naive cells functions well into old age, but memory generated from aged naive cells functions poorly | Q34390579 |
| | Evaluation of adult dTPaP vaccination coverage in France: experience in Lyon city, 2010-2011 | Q34462808 |
| | Recall responses to tetanus and diphtheria vaccination are frequently insufficient in elderly persons. | Q35070671 |
| | The effect of aging on cognate function and development of immune memory | Q36212725 |
| | Tetanus in the elderly--An important preventable disease in Australia | Q36630355 |
| | Biology of immune responses to vaccines in elderly persons | Q37150299 |
| | Response to diphtheria booster vaccination in healthy adults: vaccine trial. | Q37304697 |
| | Advocating vaccination of adults aged 60 years and older in Western Europe: statement by the Joint Vaccine Working Group of the European Union Geriatric Medicine Society and the International Association of Gerontology and Geriatrics-European Region | Q37470561 |
| | Influenza, tetanus, and pertussis vaccination coverage among adults in Germany | Q41636463 |
| | Immunogenicity and safety of one dose of diphtheria, tetanus, acellular pertussis and poliomyelitis vaccine (Repevax®) followed by two doses of diphtheria, tetanus and poliomyelitis vaccine (Revaxis®) in adults aged ≥ 40 years not receiving a diphth | Q42217195 |
| | Tetanus in Italy 2001-2010: a continuing threat in older adults | Q42235492 |
| | Promoting life course vaccination | Q43605701 |
| | Antibodies to tetanus, diphtheria and pertussis among healthy adults vaccinated according to the French vaccination recommendations | Q44290230 |
| | Immunogenicity of a combined diphtheria-tetanus-acellular pertussis vaccine in adults | Q44689536 |
| | Vaccination of adults 65 years of age and older with tetanus toxoid, reduced diphtheria toxoid and acellular pertussis vaccine (Boostrix(®)): results of two randomized trials | Q44939855 |
| | Duration of humoral immunity to common viral and vaccine antigens | Q45872621 |
| | Variation in adult vaccination policies across Europe: an overview from VENICE network on vaccine recommendations, funding and coverage. | Q46031010 |
| | Combined diphtheria-tetanus-pertussis vaccine for tetanus-prone wound management in adults | Q46981537 |
| P433 | issue | 1 | |
| P304 | page(s) | 93-99 | |
| P577 | publication date | 2016-06-09 | |
| P1433 | published in | Clinical and Experimental Immunology | Q15716708 |
| P1476 | title | Adult vaccination against tetanus and diphtheria: the European perspective | |
| P478 | volume | 187 | |